BCL11A

Gene

BCL11 transcription factor A

HGNCHGNC:13221 EnsemblENSG00000119866 NCBI Gene53335

Locus: gene with protein productLocation: 2p16.1

Encodes

via encodes

The protein product this gene encodes, reached through the canonical GENE→PROTEIN (encodes) relation. Its biology, drugs, indications, trials and therapeutic evidence live on the protein's own page.

BCL11 transcription factor AQ9H165

Protein · therapeutic target

Clinically validated target · 1 approved medicine against this target

Explore protein biology & therapeutics

Also known as

Symbols and names change; identity (the HGNC ID) does not. Previous and alternative forms are kept distinct.

Also known asEVI9 · BCL11A-XL · BCL11A-L · BCL11A-S · CTIP1 · HBFQTL5 · ZNF856 · SMARCM1

View full nomenclature history (13)

Previous symbolsEVI9

Alias symbolsBCL11A-XL, BCL11A-L, BCL11A-S, CTIP1, HBFQTL5, ZNF856, SMARCM1

Previous namesecotropic viral integration site 9, B-cell CLL/lymphoma 11A (zinc finger protein), B cell CLL/lymphoma 11A, BCL11A, BAF complex component, BAF chromatin remodeling complex subunit BCL11A

Associated diseases

via associated_with

Diseases linked to this gene through the canonical GENE→DISEASE (associated_with) relation, drawn from Open Targets' top-ranked associations by overall score — not the full association set. Disease-level detail lives on each disease's own page.

Anemia, Sickle Cell

Genetic Diseases, Inborn

Neoplasms

Benign prostatic hyperplasia

Drawn from Open Targets’ top 10 associations by overall score for this gene — the subset resolved to a canonical disease. Lower-ranked associations, and diseases not yet canonicalised, are not shown.

Gene family

HGNC gene-group membership.

Zinc fingers C2H2-typeBAF complex subunits

Provenance

HGNCCanonical human gene identity from HGNC (release 2026-07-07), updated 2023-01-20.

Open TargetsGene–disease associations from the Open Targets Platform.